Prostate cancer screenings for healthy men have always been a little controversial as it's still not clear if catching the disease early is worth the risks the screen presents, says Katherine Hobson at the Wall Street Journal's Health blog. A recent report from Bloomberg News probably won't help — according to the report, needle biopsies that follow an abnormally high PSA count from a screening are resulting more and more in severe E. coli infections. Bloomberg News goes on to say that the risk of post-biopsy infection has more than doubled in less than 10 years, with some men developing sepsis. These findings show that the screening and the tests that follow are "not necessarily benign," Hobson says, and that physicians are starting to more carefully consider the risks before ordering the test.
'Not Necessarily Benign'
May 07, 2011